Immunai vs Slate Therapeutics

Immunai vs Slate Therapeutics, compared side by side on 12 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Immunai is on 69/100 and Slate Therapeutics on 36/100.

Immunai logo
ImmunaiMapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.
Try Immunai
Slate TherapeuticsDeveloping a drug-device combination product for chronic sinusitis treatment.
Try Slate Therapeutics

Where each one leads

Immunai

  • our overall score: 69/100 against 36/100
  • agent readiness: 32/100 against 21/100

Slate Therapeutics

Leads on none of the measures we hold for both companies.

At a glance

MeasureImmunaiSlate Therapeutics
What it isMapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.Developing a drug-device combination product for chronic sinusitis treatment.
CategoryHealthcare, Immunology, Data, AnalyticsHealthcare, Medical Device, MedTech, HealthTech
Sells toBusiness modelB2BB2B
OfferingSoftwareHardware
Founded20192021
HeadquartersNew York, United StatesSan Diego, United States
StatusActiveInactive

Size, funding and growth

MeasureImmunaiSlate Therapeutics
Employees179Not published
Headcount growthLast 12 months+13.0%Not published
Total funding$295MNot published
Latest roundSeries BNot published
Valuation$1.0BNot published
LinkedIn followers26,832Not published

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureImmunaiSlate Therapeutics
StartupHub scoreOur 0-100 rating69/10036/100
Traction60/100Not published
Team70/10090/100
Search visibility39/1002/100
Quality78/10045/100
Agent readinessHow well an AI agent can read and act on the siteF (32/100)F (21/100)
Domain ratingLink authority, 0-10046/100Not published

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureImmunaiSlate Therapeutics
CMSWordPressNot detected
FrameworksJquery, BootstrapNot detected
AnalyticsGoogle Tag ManagerNot detected

Immunai vs Slate Therapeutics: common questions

Which is better, Immunai or Slate Therapeutics?

On our 0-100 score Immunai rates higher (69/100 against 36/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 12 data points above: read the rows that match what you are buying for.

How do Immunai and Slate Therapeutics compare on the numbers?

Immunai leads on our overall score (69/100 against 36/100), agent readiness (32/100 against 21/100).

Read the full Immunai review and pricing or the Slate Therapeutics review and pricing. You can also browse other Immunai alternatives we track.